|
SETD4 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.13829999999859E-05 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
2.100700E-03 |
| Normal-vs-Stage2 |
9.591900E-04 |
| Normal-vs-Stage3 |
1.70747999999055E-05 |
| Normal-vs-Stage4 |
5.515100E-03 |
| Stage1-vs-Stage2 |
1.871570E-01 |
| Stage1-vs-Stage3 |
2.342200E-02 |
| Stage1-vs-Stage4 |
3.790200E-01 |
| Stage2-vs-Stage3 |
7.651000E-01 |
| Stage2-vs-Stage4 |
8.942000E-01 |
| Stage3-vs-Stage4 |
6.845000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.29949999999146E-05 |
| Normal-vs-AfricanAmerican |
1.461140E-03 |
| Normal-vs-Asian |
9.259800E-02 |
| Caucasian-vs-AfricanAmerican |
5.929200E-01 |
| Caucasian-vs-Asian |
9.336300E-02 |
| AfricanAmerican-vs-Asian |
8.068400E-02 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.804600E-03 |
| Normal-vs-Female |
5.70559999999443E-05 |
| Male-vs-Female |
2.137200E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.064830E-03 |
| Normal-vs-Age(41-60Yrs) |
1.756260E-04 |
| Normal-vs-Age(61-80Yrs) |
7.92950000000348E-05 |
| Normal-vs-Age(81-100Yrs) |
9.399800E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.413000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.775380E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.006600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.126800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.035800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.545600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.83989999996892E-06 |
| Classical-VS-Follicular |
6.348600E-01 |
| Classical-VS-Other |
9.303800E-02 |
| Classical-VS-Normal |
9.795200E-04 |
| Tall-VS-Follicular |
1.022390E-04 |
| Tall-VS-Other |
2.053700E-02 |
| Tall-VS-Normal |
5.80720027620885E-10 |
| Follicular-VS-Other |
2.229600E-01 |
| Follicular-VS-Normal |
1.590150E-02 |
| Other-VS-Normal |
7.259600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.82979999999412E-05 |
| Normal-vs-N1 |
3.062100E-03 |
| N0-vs-N1 |
7.001400E-01 |
|
|
